NCT06687291Recruiting
Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
The primary objective of this observational study is to investigate the incidence of Post Operative Delirium (POD) after gastroesophageal cancer surgery. Secondary objectives are to investigate the relationship between POD, preoperative depression, frailty, quality of life, malnutrition and sarcopenia. Participants identified with POD will be asked (at the routine follow-up meeting after surgery) to participate in an qualitative interview, in order to understand the participant's experience of postoperative delirium. The main objective aims to answer: What is the incidence of POD after gastroesophageal cancer surgery.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 130 (estimated)
- First submitted
- 7 Nov 2024
- Start date
- 13 Feb 2025
- Primary completion date
- 11 Nov 2027
- Lead sponsor
- Karolinska Institutet
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06687291
What you commit to
- Study type: Observational
- Planned participants: 130
- From 13 Feb 2025 to the primary completion date, 11 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with ongoing drug and/or alcohol abuse.
Other illness
- Patients with preoperative cognitive dysfunction such as dementia.
Other
- Patients who are inoperable due to metastases.
- Patients unable to communicate due to severely impaired hearing and/or - seeing.
- Patients who cannot give informed consent.
Who the study is looking for
- Patients diagnosed with esophageal or gastric cancer, treated with (or without) chemotherapy and surgery.
- Age ≥18 at the time for inclusion.
- Participate on a voluntary basis and can (for any reason) end its participation during the study.
- Capable of giving informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska University Hospital, Huddinge Coordinator of this site? Confirm its status | Huddinge | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.